Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Current Deferred Tax Assets (2020)

Terns Pharmaceuticals (TERN) has disclosed Current Deferred Tax Assets for 1 consecutive years, with $2.1 million as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Current Deferred Tax Assets changed N/A year-over-year to $2.1 million, compared with a TTM value of $2.1 million through Dec 2020, changed N/A, and an annual FY2020 reading of $2.1 million, changed N/A over the prior year.
  • Current Deferred Tax Assets was $2.1 million for Q4 2020 at Terns Pharmaceuticals.
  • Across five years, Current Deferred Tax Assets topped out at $2.1 million in Q4 2020 and bottomed at $2.1 million in Q4 2020.